PRAS40 prevents development of diabetic cardiomyopathy and improves hepatic insulin sensitivity in obesity.
Mechanistic target of rapamycin complex 2 protects the heart from ischemic damage.
Pathological hypertrophy amelioration by PRAS40-mediated inhibition of mTORC1.
Regulation of cardiac hypertrophic signaling by prolyl isomerase Pin1.
Pim-1 kinase protects mitochondrial integrity in cardiomyocytes.